Reflecting on 30 Years of Supporting Rare Disease Patients Worldwide
Bonnie Anderson, Humanitarian Programs Head, Sanofi Genzyme
In this episode, Bonnie Anderson speaks about Sanofi’s humanitarian program for rare diseases and its patient impact. The program started in 1991 when its first treatment for Gaucher disease was made available and it has since expanded to support five different communities with lysosomal storage disorders—a group of rare genetic conditions caused by enzyme deficiencies—around the world.
Also check out a related article on this topic using the link below.